Decheng Capital
About Us
Team
Portfolio
News
Contact
A Global Life Sciences Investment Firm
Established in 2012
$2.1 Billion of Capital
Building Legendary Companies
In The News
October 13, 2014
Invitae Completes $120 Million Series F Financing
July 2, 2014
GeneWeave Attracts $12 Million to Provide Same-Shift Sample-In/Susceptibility-Out Diagnostic Solutions for Multi-Drug-Resistant Organisms
March 6, 2014
Mr. Robert King, Decheng’s Co-Anchor LP, Received the 2014 Arbuckle Award
February 14, 2014
Yuri Milner-Backed Company Prepares IPad-Size DNA Sequencer
Archive
2022
2021
2019
2018
2017
2016
2015
2014
2013
2012
